tetradecanoylphorbol acetate has been researched along with rhodioloside in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, YH; Xu, SP | 1 |
| Kim, H; Kong, CS; Seo, Y | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and rhodioloside
| Article | Year |
|---|---|
Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Cytokines; Drug Administration Schedule; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Mice; Phenols; Random Allocation; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2018 |
Salidroside, 8(
Topics: Fibrosarcoma; Fruit; Glucosides; Humans; Ligustrum; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Phenols; Pyrans; Tetradecanoylphorbol Acetate | 2022 |